You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR PROTAMINE ZINC INSULIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Protamine Zinc Insulin

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00348231 ↗	Jikei Optimal Insulin Therapy in Type 2 Diabetes	Unknown status	Novo Nordisk A/S	N/A	2004-11-01	The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.
NCT00348231 ↗	Jikei Optimal Insulin Therapy in Type 2 Diabetes	Unknown status	Jikei University School of Medicine	N/A	2004-11-01	The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.
NCT00474045 ↗	Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes	Completed	Novo Nordisk A/S	Phase 3	2007-05-01	This trial is conducted in Africa, Europe, North and South America and Oceania. The aim of this trial is to compare the effect and safety on blood glucose control in pregnant women with type 1 diabetes of a modern insulin analogue (insulin detemir) and human insulin (NPH insulin) given as long-acting insulin in combination with a short-acting insulin (insulin aspart).
NCT00487240 ↗	Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes	Completed	Eli Lilly and Company	Phase 3	2007-06-01	The purpose of this study is to examine the efficacy and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.
NCT00490854 ↗	A Study for Patients With Type 2 Diabetes Mellitus	Completed	Alkermes, Inc.	Phase 2/Phase 3	2007-07-01	The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.
NCT00490854 ↗	A Study for Patients With Type 2 Diabetes Mellitus	Completed	Eli Lilly and Company	Phase 2/Phase 3	2007-07-01	The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Protamine Zinc Insulin

Condition Name

Chart
Table

Condition Name for Protamine Zinc Insulin
Intervention	Trials
Diabetes Mellitus, Type 2	16
Diabetes	8
Type 2 Diabetes Mellitus	7
Type 1 Diabetes Mellitus	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Protamine Zinc Insulin
Intervention	Trials
Diabetes Mellitus	36
Diabetes Mellitus, Type 2	27
Diabetes Mellitus, Type 1	10
Hyperglycemia	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Protamine Zinc Insulin

Trials by Country

Map
Table

Trials by Country for Protamine Zinc Insulin
Location	Trials
United States	95
South Africa	11
Australia	10
Brazil	9
India	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Protamine Zinc Insulin
Location	Trials
California	7
Texas	7
New York	5
Kentucky	4
Georgia	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Protamine Zinc Insulin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Protamine Zinc Insulin
Clinical Trial Phase	Trials
Phase 4	22
Phase 3	15
Phase 2/Phase 3	1
[disabled in preview]	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Protamine Zinc Insulin
Clinical Trial Phase	Trials
Completed	41
Terminated	4
Recruiting	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Protamine Zinc Insulin

Sponsor Name

Chart
Table

Sponsor Name for Protamine Zinc Insulin
Sponsor	Trials
Sanofi	9
Eli Lilly and Company	8
Novo Nordisk A/S	7
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Protamine Zinc Insulin
Sponsor	Trials
Other	43
Industry	30
U.S. Fed	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.